# Prelude Therapeutics Inc: Form SC 13D/A, filed Dec 13, 2023

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: SC 13D/A
- Filed: 2023-12-13
- Accepted by EDGAR: Dec 13, 2023, 16:55 ET
- Period: not reported
- Accession: 0001104659-23-125744
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000110465923125744/tm2332807d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000110465923125744/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000110465923125744/tm2332807d1_sc13da.htm

Filed Dec 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-125744. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
